Literature DB >> 1490700

Diabetes mellitus and bone metabolism.

R Ziegler1.   

Abstract

Whether there is a diabetic osteopathy" or osteopathy in diabetes mellitus", is still unclear. Epidemiological studies show in part discrepant results: bone mass was diminished in some studies, unchanged in others--even more positive trends were reported. Increases in osteoporotic fractures were observed in smaller collectives whereas no general trends for fracturing bones were found in diabetics. There are many in part favouring, in part impairing factors to be taken into consideration: Diabetes mellitus type I is a disease including immune phenomena. As inflammation leads to bone loss (inflammation-mediated osteopenia = IMO), peak bone mass may be influenced by such a process. The lack of insulin-like growth factors may be decisive, too. Complications of diabetes mellitus include hypogonadism--this may be disadvantageous for the skeleton. Diabetic complications like retinopathy, neuropathy, and angiopathy may influence the fracture event independently from bone mass. On the other hand, diabetes mellitus type II may be somehow protected against bone loss: Increased adipose tissue in connection with the frequently seen overweight yields metabolically active steroid hormones, insulin related growth factors may stimulate bone formation (e.g. in Forestier's disease). Older diabetics do not show diminished life expectancy any more due to their regular medical care--whether this includes the risk of bone diseases, is not yet clear. It may be worth to further analyse these "positive" effects seen in bones of type II diabetics because they may be useful in osteoporosis even in non-diabetics.

Entities:  

Mesh:

Year:  1992        PMID: 1490700

Source DB:  PubMed          Journal:  Horm Metab Res Suppl        ISSN: 0170-5903


  6 in total

Review 1.  Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.

Authors:  William J Jeffcoate
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

Review 2.  Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?

Authors:  W Jeffcoate
Journal:  Diabetologia       Date:  2004-08-21       Impact factor: 10.122

3.  Increasing serum osteocalcin after glycemic control in diabetic men.

Authors:  S Sayinalp; O Gedik; Z Koray
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

4.  High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis.

Authors:  Y Wittrant; Y Gorin; K Woodruff; D Horn; H E Abboud; S Mohan; S L Abboud-Werner
Journal:  Bone       Date:  2008-02-29       Impact factor: 4.398

5.  Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes.

Authors:  Yuichi Takashi; Minae Koga; Yoko Matsuzawa; Jun Saito; Masao Omura; Tetsuo Nishikawa
Journal:  J Diabetes Investig       Date:  2017-01-25       Impact factor: 4.232

Review 6.  Sweet Bones: The Pathogenesis of Bone Alteration in Diabetes.

Authors:  Mohammed Al-Hariri
Journal:  J Diabetes Res       Date:  2016-09-29       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.